ATRA Stock Analysis: Buy, Sell, or Hold?
ATRA - Atara Biotherapeutics, Inc
$11.17
0.66 (6.28%)
▲
5d:
+5.28%
30d:
-0.8%
90d:
+143.36%
HOLD
MODERATE Confidence
Analysis Updated: Jun 29, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When ATRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ATRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ATRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.43
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$18.89
40.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRA is currently trading at $11.17, which is considered extended relative to its 30-day fair value range of $9.67 to $10.69. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.8) compared to its historical average (17.1). Remarkably, the market is currently pricing in an annual earnings decline of 19.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ATRA is in a strong uptrend. Immediate support is located at $9.21, while resistance sits at $11.55. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.67 (+22.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATRA is in a strong uptrend. Immediate support is located at $9.21, while resistance sits at $11.55. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.67 (+22.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.67 -
$10.69
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.7%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- BULLISH: Trading 22.4% below Wall St target ($13.67)
Trading Range Analysis
30-Day Trading Range
$9.67 -
$10.69
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.21
Resistance Level
$11.55
Current Trend
Strong Uptrend
Technical data as of
Jun 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.80
Wall Street Target
$13.67
(+22.4%)
Revenue Growth (YoY)
-99.5%
Profit Margin
-40.9%
Valuation Discount vs History
-19.9% cheaper
PE vs Historical
8.8 vs 17.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.9%
(market-implied from PE analysis)
1-Year Target
$10.05
(-10%)
2-Year Target
$9.05
(-19%)
3-Year Target
$8.14
(-27%)
3-Yr Target (if PE normalizes)
(PE: 9→17)
$15.83
(+42%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.8 to 17.1
Stabilization Target:
$21.72
(+94.4%)
PE Expansion Potential:
+94.4%
Share & Embed Analysis
Last updated: June 29, 2026 6:18 PM ET
Data refreshes hourly during market hours. Next update: 7:18 PM
Data refreshes hourly during market hours. Next update: 7:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Innovation Ltd Panacea
SELL
80554 shares
2026-01-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 58 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
